Junna Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 2.91 Cr
as on 23-10-2024
- Company Age 18 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 47.80 Cr
as on 23-10-2024
- Satisfied Charges ₹ 2.56 Cr
as on 23-10-2024
- Revenue -15.33%
(FY 2023)
- Profit -54.33%
(FY 2023)
- Ebitda -102.95%
(FY 2023)
- Net Worth 0.13%
(FY 2023)
- Total Assets -20.41%
(FY 2023)
About Junna Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.91 Cr.
The company currently has active open charges totaling ₹47.80 Cr. The company has closed loans amounting to ₹2.56 Cr, as per Ministry of Corporate Affairs (MCA) records.
Narendar Idula, Durga Reddy, Shekar Junna, and One other member serve as directors at the Company.
- CIN/LLPIN
U24110TG2006PTC049983
- Company No.
049983
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Junna Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendar Idula  | Director | 26-Aug-2006 | Current |
| Durga Reddy | Director | 26-Aug-2006 | Current |
| Shekar Junna | Director | 20-Apr-2006 | Current |
| Basvi Junna | Director | 20-Apr-2006 | Current |
Financial Performance of Junna Life Sciences.
Junna Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.33% decrease. The company also saw a substantial fall in profitability, with a 54.33% decrease in profit. The company's net worth moved up by a moderate rise of 0.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Junna Life Sciences?
In 2023, Junna Life Sciences had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vepco Bio-Tech Private LimitedActive 28 years 8 monthsNarendar Idula and Shekar Junna are mutual person
- Vinayaka Cotton Mills Private LimitedActive 29 years 8 months
Durga Reddy and Shekar Junna are mutual person
- Feno Business Solutions Private LimitedActive 15 years 1 month
Durga Reddy and Basvi Junna are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Aug 2021 | ₹25.00 Cr | Open |
Others Creation Date: 18 Jul 2017 | ₹22.80 Cr | Open |
Yes Bank Limited Creation Date: 18 Mar 2013 | ₹8.50 M | Satisfied |
How Many Employees Work at Junna Life Sciences?
Unlock and access historical data on people associated with Junna Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Junna Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Junna Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
